Drug Trial Radar · NCT00688909
Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer
Last checked: Nov 20, 2026Latest source record: Jun 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
261
Actual
Start
Mar 2008
Primary completion
Jun 2009
Study completion Jun 2009
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Jun 3, 2008
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- Who can join
- Female only, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate whether patients who are intolerant and discontinue anastrozole due to grade 2-3 arthralgia-myalgia have a decrease in rheumatological symptoms while taking letrozole
Conditions
- Breast Cancer
Interventions
letrozoleDrug
2.5 mg daily by mouth for 6 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Discontinuing Due to Grade 2 or Higher Arthralgia-myalgia.Time frame: End of Study (24 weeks)
Locations
48 sites in 1 country. Site status is shown where the registry gives one.
Clearview Cancer Center
Huntsville, Alabama
Hematology Oncology Services of Arkansas
Little Rock, Arkansas
Grass Valley Hematology Oncology
Grass Valley, California
Aptium Oncology - Comprehensive Cancer Care of the Desert
Palm Springs, California
Bay Area Cancer Research Group
Pleasant Hill, California
Front Range Specialist
Fort Collins, Colorado
Lynn Cancer Center
Boca Raton, Florida
Florida Cancer Specialists
Fort Myers, Florida
Memorial Cancer Center
Hollywood, Florida
Palm Beach Cancer Specialists
West Palm Beach, Florida
Northeast Georgia Cancer Care, LLC
Athens, Georgia
Augusta Oncology
Augusta, Georgia
Oncology Specialist of North Georgia
Gainesville, Georgia
The Cancer Instiute at Alexian Brothers
Elk Grove Village, Illinois
Evanston Northwestern Hospital
Evanston, Illinois
Edward H. Kaplan MD & Associates - North Shore Cancer Research Associates
Skokie, Illinois
Cancer Care of Kansas
Wichita, Kansas
Kentuckiana Cancer Institute
Louisville, Kentucky
Mercy Hospital
Portland, Maine
Mercey Hospital
Baltimore, Maryland
Maryland Hematology Oncology Associates, PA
Baltimore, Maryland
Suburban Hospital Cancer Program
Bethesda, Maryland
Hematology Oncology Asssociates of Ohio & Michigan
Lambertville, Michigan
Center for Cancer Care and Research
St Louis, Missouri
Ballas Cancer Center, LLC DBA - St Louis
St Louis, Missouri
Southeast Nebraska Hematology & Oncology Consultants
Lincoln, Nebraska
Trinitas Comprehensive Cancer Center
Elizabeth, New Jersey
Hematology-Oncology Assoc of Northern New Jersey
Morristown, New Jersey
Somerset Hematology & Oncology
Somerville, New Jersey
Cooper University Hospital
Voorhees Township, New Jersey
Broom Oncology
Binghamton, New York
Cancer Care of W. NC
Asheville, North Carolina
Marion L. Shepard Cancer Center
Washington, North Carolina
Summa Health System
Akron, Ohio
Mukesh Bhatt, MD, INC.
Medina, Ohio
Berks Hematology Oncology
West Reading, Pennsylvania
South Carolina Oncology Associates
Columbia, South Carolina
The West Clinic
Memphis, Tennessee
Tenessee Oncology
Nashville, Tennessee
Coastal Bend Cancer Center
Corpus Christi, Texas
Showing 40 of 48 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.